People with type 1 diabetes should be screened regularly for obesity and chronic kidney disease, according to a study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
In a study published Jan. 24 in The Lancet Regional Health – Americas, Scott Pilla, M.D., M.H.S., an assistant professor of medicine at the Johns Hopkins University School of Medicine, Ahmed Elhussein, M.P.H, Jeanne Clark, M.D., M.P.H and their colleagues conducted a study to determine how often patients of different racial or ethnic groups started newer diabetes medications.
Researchers at the Icahn School of Medicine at Mount Sinai discovered that the chance a pathogenic genetic variant may actually cause a disease is relatively low - about 7 percent. They also found that some variants, such as those associated with breast cancer, are linked to a wide range of risks for disease. The results could alter the way the risks associated with these variants are reported, and one day, help guide the way physicians interpret genetic testing results.
To reach larger audiences of individuals with endocrine conditions, particularly those in underserved communities, the Endocrine Society is expanding its in-person health education events and launching a new consumer health education web presence.
Middle-aged men who are anxious and worry more may be at greater biological risk for developing heart disease, stroke and type 2 diabetes, also called cardiometabolic disease, as they get older, according to new research published today in the Journal of the American Heart Association, an open access journal of the American Heart Association.
Joslin researchers show how one form of the rare inherited disease known as mature onset diabetes of the young (MODY) is driven by mutated digestive enzymes generated in pancreatic exocrine cells that are then taken up by neighboring insulin-secreting beta cells.
The newly sworn-in Mayor of New York City, Eric Adams, is interviewed by Stephen Ritz in 2020 while he was Brooklyn Borough President. They talk in depth about his career, health, wellness, school food, and his visit to Green Bronx Machine to cook with students.
UC San Diego Herbert Wertheim School of Public Health study reports that the more steps taken, and the more intense, the lower the risk of Type 2 diabetes among women 65 and older.
Despite a year of unparalleled challenges, including a pandemic, travel restrictions and redirected funding, Arizona State University continues to grow its research enterprise and advance new discoveries and solutions.
A study led by UC Davis has found significant gut bacteria profile differences between Black and white women, even after accounting for their insulin sensitivity status.
Researchers from the University of Eastern Finland, the University of Exeter, Cardiovascular Engineering Inc., and the University of Bristol carried out the study using data from one of the world’s most extensive ongoing prospective birth cohort studies – the Avon Longitudinal Study of Parents and Children (ALSPAC).
Findings from a first-of-its-kind study conducted at University Hospitals Harrington Heart & Vascular Institute showed a novel system-wide interdisciplinary team assembled to evaluate alternative treatments to major amputation improved outcomes for patients with Critical Limb-Threatening Ischemia.
مدينة روتشستر، ولاية مينيسوتا- أمراض القلب مثل مرض الشريان التاجي وعوامل الخطر القلبية الوعائية مثل مرض السكري وارتفاع الكوليسترول مرتبطة بشكل أقوى بتراجع الذاكرة ومهارات التفكير في منتصف العمر لدى النساء مقارنة بالرجال، بحسب دراسة أجرتها مايو كلينك، على الرغم من انتشار هذه الحالات بشكل أكبر بين الرجال. هذا البحث منشور في مجلة علم الأعصاب، المجلة الطبية للأكاديمية الأمريكية لطب الأعصاب.
Problemas cardíacos como a doença arterial coronariana e fatores de risco cardiovasculares como diabetes e colesterol alto têm maior associação com declínio nas habilidades de memória e raciocínio durante a meia-idade para mulheres do que para homens, mostra um estudo da Mayo Clinic.
Cancer, infections and heart disease pose the greatest risk to kidney transplant recipients ― not organ rejection ― according to a recently published Mayo Clinic study. Researchers discovered that recipient death due to factors other than organ rejection is the leading cause for transplanted kidney loss. Only 1 in 4 transplanted kidney losses were caused by organ rejection.
Las afecciones cardíacas, como la enfermedad arterial coronaria, y los factores de riesgo cardiovascular, como la diabetes y el colesterol alto, tienen una relación más fuerte con el deterioro de la capacidad de pensamiento y memoria en las mujeres de mediana edad que en los hombres
Members of the media can now register to cover the latest advances in hormone health and science at ENDO 2022, the Endocrine Society’s annual meeting being held on June 11-14 in Atlanta, Ga., as well as virtually in our state-of-the-art digital platform. The Society’s first-ever hybrid annual meeting will give colleagues the option to experience top-flight educational programming in person as well as reconnect with endocrine colleagues.
A Mayo Clinic study shows heart conditions such as coronary artery disease and cardiovascular risk factors such as diabetes and high cholesterol have stronger association with decline in memory and thinking skills during midlife for women than men. That's despite a higher prevalence of those conditions in men. The research is published in Neurology, the medical journal of the American Academy of Neurology.
Minnesota has the lowest age-adjusted heart disease mortality in the U.S.; yet, African American adults 35 to 63 have nearly double the rate of death from cardiovascular disease, compared to their white counterparts.
Diabetic neuropathy refers to nerve damage due to diabetes and it may lead to pain and numbness, most often in the hands and feet. To help neurologists and other doctors determine the best treatment for people with diabetic neuropathy, the American Academy of Neurology (AAN) has issued a guideline on oral and topical treatments for painful diabetic neuropathy. The guideline is published in the December 27, 2021, online issue of Neurology®, the medical journal of the AAN, and is endorsed by the American Association of Neuromuscular & Electrodiagnostic Medicine. This guideline updates the 2011 AAN guideline on the treatment of painful diabetic neuropathy.
People with diabetes may need to monitor their blood sugar more closely when doing high-altitude activities such as hiking or skiing, according to a small study published in the Society’s Journal of Clinical Endocrinology & Metabolism.
GLP-1 RA treats diabetes and is linked to positive outcomes for heart disease patients, yet inequities were found in its use along racial, ethnic, and economic lines
Results of a 12-month multicenter randomized clinical trial led by Erika Petersen, M.D., a professor of neurosurgery at the University of Arkansas for Medical Sciences (UAMS), were published online Nov. 29 in Diabetes Care, highlighting the benefits of a breakthrough treatment for patients with painful diabetic neuropathy (PDN).
A custom computer program at Children’s Hospital Los Angeles is translating into enhanced patient safety, streamlined workflow—and fewer finger sticks for children with diabetes. The program is a new insulin calculator that is seamlessly integrated into the hospital’s electronic health record (EHR) system.
The gap in the use of insulin pumps and continuous glucose monitors (CGMs) among Black and white Medicare beneficiaries widened from 2017-2019, according to new research published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
A new study in mice shows transplanted brown fat can reduce type 2 diabetes risk factors after a heart attack, an encouraging finding for scientists who hope to apply the so-called “good” fat’s beneficial properties to drugs that can help prevent health problems.
A new review explores the physiology behind and proposed management strategies for body-wide symptoms of the post-acute sequelae of SARS-CoV-2 (PASC), otherwise known as “long COVID.” The review is published ahead of print in the American Journal of Physiology-Cell Physiology.
The Endocrine Society urges the Senate to protect the insulin affordability provisions included in the Build Back Better Act and move quickly to pass this crucial legislation.
Findings from a new study led by Yale Cancer Center show the small molecule inhibitor drug, PF05175157, originally developed to treat diabetes by Pfizer, may help in the treatment of breast cancer. The findings were reported today at the 2021 San Antonio Breast Cancer Symposium in San Antonio, Texas.
Scientists have discovered that gene therapy and the diabetes drug metformin may be potential treatments for late-onset retinal degeneration (L-ORD), a rare, blinding eye disease. Researchers from the National Eye Institute (NEI), part of the National Institutes of Health generated a “disease-in-a-dish” model to study the disease. The findings are published in Communications Biology.
Using artificial intelligence, a team of University at Buffalo researchers has developed a novel system that models the progression of chronic diseases as patients age.
Researchers at Penn State College of Medicine are seeking volunteers from across the U.S. to participate in a clinical trial examining whether online mindfulness-based stress reduction can reduce stress and average blood sugar levels in those with Type 1 or Type 2 diabetes.
Transgender women may be at higher risk for type 2 diabetes compared to cisgender women, but not to cisgender men, according to new research published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
The Endocrine Society hailed the House of Representatives for including provisions to improve insulin affordability in its version of the Build Back Better Act.
Researchers at the University of New Hampshire have found that variants of the cone snail venom could offer possibilities for developing new fast-acting drugs to help treat diabetes.
People with type 2 diabetes who contract COVID-19 are nearly 50% more likely to wind up in intensive care if they have poorly managed their blood sugar levels over the long-term than those with better long-term glycemic control, according to a study using anonymized health care data.
Studies suggest that exposure to the COVID-19 pandemic has been associated with a variety of different mental health consequences including reports of depression, loneliness, and insomnia. People who are more than 65 years of age and those with underlying medical conditions such as type 2 diabetes and obesity are particularly vulnerable to negative outcomes from COVID-19. Until now, few investigations have identified and separated the mental health consequences of exposure to the COVID-19 pandemic from preexisting factors in this age group. A new prospective study of a large cohort of older adults with type 2 diabetes and overweight/obesity from across the U.S. has explored this subject with surprising results.
In COVID-19 patients, obesity is the factor most associated with the development of endothelial dysfunction, a condition in which the blood vessels become unable to contract and relax adequately, increasing the risk of events such as heart attacks, thrombosis (blood clotting), and stroke.
Consuming a low amount of caffeine during pregnancy could help to reduce gestational diabetes risk, according to researchers in the Perelman School of Medicine at the University of Pennsylvania.
In an experiment to find an effective treatment for diabetic foot ulcers, which affect 62 million people worldwide, a team led by University of South Australia physicist Dr Endre Szili has made an unexpected discovery: the same technology kills the SARS-CoV-2 virus.